NCT04328844 2026-03-30A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersiOncturaPhase 1 Active not recruiting210 enrolled
NCT04993677 2025-05-11A Study of SEA-CD40 Given With Other Drugs in CancersSeagen Inc.Phase 2 Completed77 enrolled 18 charts